- Home
- NPCT vs TKNO Comparison
NPCT vs TKNO Comparison
Compare NPCT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCT
- TKNO
- Stock Information
- Founded
- NPCT 2020
- TKNO 1996
- Country
- NPCT United States
- TKNO United States
- Employees
- NPCT N/A
- TKNO N/A
- Industry
- NPCT Investment Managers
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- NPCT Finance
- TKNO Health Care
- Exchange
- NPCT Nasdaq
- TKNO Nasdaq
- Market Cap
- NPCT 306.8M
- TKNO 356.4M
- IPO Year
- NPCT N/A
- TKNO 2021
- Fundamental
- Price
- NPCT $11.22
- TKNO $5.06
- Analyst Decision
- NPCT
- TKNO Buy
- Analyst Count
- NPCT 0
- TKNO 1
- Target Price
- NPCT N/A
- TKNO $5.00
- AVG Volume (30 Days)
- NPCT 107.1K
- TKNO 330.7K
- Earning Date
- NPCT 01-01-0001
- TKNO 08-12-2025
- Dividend Yield
- NPCT 9.82%
- TKNO N/A
- EPS Growth
- NPCT N/A
- TKNO N/A
- EPS
- NPCT N/A
- TKNO N/A
- Revenue
- NPCT N/A
- TKNO $38,250,000.00
- Revenue This Year
- NPCT N/A
- TKNO $8.73
- Revenue Next Year
- NPCT N/A
- TKNO $16.53
- P/E Ratio
- NPCT N/A
- TKNO N/A
- Revenue Growth
- NPCT N/A
- TKNO 3.79
- 52 Week Low
- NPCT $8.58
- TKNO $1.16
- 52 Week High
- NPCT $10.63
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- NPCT 70.75
- TKNO 32.47
- Support Level
- NPCT $10.55
- TKNO $4.72
- Resistance Level
- NPCT $10.75
- TKNO $5.65
- Average True Range (ATR)
- NPCT 0.10
- TKNO 0.35
- MACD
- NPCT 0.02
- TKNO -0.05
- Stochastic Oscillator
- NPCT 96.15
- TKNO 27.37
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to seek total return through high current income and capital appreciation, while giving special consideration to certain impact and environmental, social and governance criteria.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.